Franklin, Tenn.-based Acadia Healthcare revised its 2025 financial guidance following higher-than-expected professional and general liability expenses.
The health system now expects full-year 2025 adjusted EBITDA to be between $601 million and $611 million, down from its prior range of $650 million to $660 million, according to a Dec. 2 news release. Adjusted earnings per share are projected at $1.94 to $2.04, compared to earlier guidance of $2.35 to $2.45.
Acadia attributed the revisions to an incremental $49 million in PLGL expenses identified in a final third-party actuarial review. Total PLGL expenses for 2025 are projected at approximately $116 million, up from $54 million in 2024.
Key drivers include higher expected settlement costs for legacy claims, a 168% increase in claim frequency for the 2025 policy year, elevated incurrent-but-not-reported reserves and less favorable reinsurance terms.
Acadia’s net PLGL liability is expected to rise from $78 million at year-end 2024 to between $145 million and $165 million at year-end 2025. For 2026, PLGL expenses are projected to be between $100 million and $110 million, the release said.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
